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We report the successful hemodialysis via access to the portal vein in a patient whose 
jugular, subclavian and femoral veins were all exhausted. 
 
A fifty-year-old woman suffered from end stage renal failure due to lupus nephritis. 
She was switched to hemodialysis after ten years of peritoneal dialysis. Creation of 
arterio-venous fistulae or grafts in both upper limbs was unsuccessful and catheter 
thrombosis occurred in the jugular, subclavian and femoral regions bilaterally. The 
anterior branch of the right portal vein was cannulated using a 21-G needle under 
fluoroscopic guidance. A Retrocath® (45 cm long; 16 Fr) was then lodged into the 
portal venous system [Figure 1] and this catheter remained functional for 3 months. 
 
In localities where peritoneal dialysis is the predominant mode of renal replacement 
therapy, the initial creation of AV fistulae or grafts is often problematic when patients 
require hemodialysis. This may be due to extensive calcifications aggravating 
vasculopathic changes with increased dialysis vintage. Placement of tunneled catheter 
in the traditional sites became increasingly difficult. In this context, the transhepatic 
approach is a promising solution to the problem. This approach was first described by 
Po et al. in 1994.1 Later, Stavropoulos et al.2 reported a series with a high technical 
success rate of catheter insertion but a low mean primary and secondary patency 
duration. Complications associated with the transhepatic approach, though infrequent, 
include line sepsis, catheter migration, thrombosis and bleeding.2,3 Hemorrhagic 
pleural effusion and intra-peritoneal hemorrhage, though rare, can be 
life-threatening.2,3 These complications can be minimized when the procedure is 
performed by an interventional radiologist who is familiar with portal venous 
cholangiography as in our case. Alternative approaches such as percutaneous 
trans-renal or trans-lumbar IVC cannulation have also been described.4,5 Expertise to 
cannulating these venous systems is a prerequisite. 
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Figure Legend 
 
Fig. 1 Transhepatic placement of a Retrocath® (45cm long; 16 Fr) into the portal vein. 
Contrast was injected to confirm the successful cannulation of the portal venous 
system. 
 
